Nancy Ryerson

Nancy Ryerson is a digital communicator with years of experience covering healthcare. Today, she's a Digital Marketing Manager at Antidote, where she manages the company's content marketing and SEO strategies. Prior to joining Antidote, Nancy spent three years at The Michael J. Fox Foundation, where she created content for Parkinson's disease patients and expanded the Foundation's email list by 100,000+ members in two years through search and social strategies. She holds a BA in English and journalism from NYU.

Find me on:

5 New Rules for Clinical Trial Patient Recruitment

Since the first controlled clinical trial way back in 1747, researchers have needed patient volunteers to take part. We don't know how difficult it was for James Lind to find 12 sailors willing to try a treatment for scurvy, but we're sure he had to make a strong pitch that focused on the benefit to them as patients.

Continue reading

What’s the Latest Research on Idiopathic Pulmonary Fibrosis?

Idiopathic Pulmonary Fibrosis (IPF) is a rare, difficult-to-treat lung disease affecting around 100,000 patients in the U.S. While two medications have been approved to slow IPF progression, there are currently no approved treatments that can stop or reverse the disease.

Continue reading

Advertising Clinical Trials: What Works in 2019

There are more approaches to advertising clinical trials than ever before, from digital advertising, to site databases, to sharing materials in doctors' offices. Unfortunately, trial protocols have become more complex at the same time outreach options have expanded. Despite the best efforts of the industry, 73% of Americans don't even know anyone who has participated in a trial, let alone joined ...

Continue reading

After a Surprise Kidney Disease Diagnosis, This Patient Turned to Education and Advocacy

Patrick Gee didn't know that there were any problems with his kidneys until a doctor diagnosed him with kidney failure. Years on dialysis, four surgeries, 47 days in the hospital, and one successful kidney transplant later, he's participated in two clinical trials and become a proud advocate for the American Kidney Fund.

Continue reading

What Questions Should I Ask Before Joining a Clinical Trial?

Joining a clinical trial is a significant decision, and there are several personal factors to keep in mind when deciding whether to join – not to mention including the opinions of family members and your doctor.

Continue reading

How Long Before Levodopa Stops Working in Parkinson’s?

Levodopa works to reduce symptoms in Parkinson's for as long as a patient takes it. However, as the underlying disease progresses and Parkinson's symptoms get worse, patients may need to increase their dose or take levodopa more frequently to experience the same reduction in symptoms.

Continue reading

How to Read a Clinical Trial Study Page

 

Continue reading

You Searched for a Clinical Trial. Now What?

At Antidote, we talk a lot about how our search tool makes it easier to match with clinical trials you may qualify for. But what happens after you conduct your search?

Continue reading

It’s a Promising Time for Parkinson’s Disease Research – Here’s Why

It's an exciting time to consider participating in Parkinson's research, says Katie Kopil, PhD, Director of Research Partnerships at The Michael J. Fox Foundation for Parkinson's Research (MJFF).

Continue reading

How the American Kidney Fund Connects Patients with Research

Chronic kidney disease (CKD) is one of the top-ten causes of death in the United States – but 96% of people in its early stages don't even know they have it.

Continue reading

Get our latest posts in your inbox.